[1. Selby JV, Ray GT, Zhang D, et al. Excess costs of medical care for patients with diabetes in managed care population. Diabetes Care. 1997; 20: 1396-1402. 1b. Berry J, Keebler Me, McGuire DK. Diabetes Mellitus and Cardiovascular Disease: Pandora's Box has been opened. Herz. 2004; 29(5): 456-62.]Search in Google Scholar
[2. Kissela BM, Khoury J, Kleindorfer D, et al. Epidemiology of Ischemic Stroke in Patients with Diabetes. The Greater Cincinnati/Northern Kentucky Stroke study. Diabetes care. 2005; 28: 355-359.10.2337/diacare.28.2.355]Search in Google Scholar
[2b. Van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Vermeulen G, Gorter JW, et al. Long-term survival and vascular event risk after transient ischemic attack or minor ischemic stroke: a cohort study. Lancet. 2005; 365(9477): 2098-104.10.1016/S0140-6736(05)66734-7]Search in Google Scholar
[3. Sacco RL, Boden-Albala B, Abel G, Lin IF, Elkind M, Hause WA, et al. Race-ethnic disparities in in the impact of stroke risk factors in Northern Manhattan Stroke study. Stroke. 2001; 32: 1732-5. 3b. Mallick U, Dorobantu M, Iqbal B, Cheta D. An evidence based approach to the management of cardiovascular disease in Diabetes mellitus. In Cheta D. Vascular Involvment in Diabetes. Carger, Basel 2005.]Search in Google Scholar
[4. Yamanouchi H, Shimada H, Kuramoto K. Subtypes and proportions of cerebrovascular disease in an autopsy series in a Japanese geriatric hospital. (Tokyo Metropolitan Geriatric Hospital series) Klin Wochenschr. 1990; 68: 1173-7.10.1007/BF018152732280580]Search in Google Scholar
[5. Hillen T, Coshal C, Tilling K. on behalf of the South London Stroke register. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcome of stroke recurrence: The South London Stroke Register. Stroke. 2003; 34: 1457-63.10.1161/01.STR.0000072985.24967.7F12750544]Search in Google Scholar
[6. Kuusisto J, Mykkanene L, Pyorala K, Laakso M. Noninsulin dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994; 25: 1157-64.10.1161/01.STR.25.6.1157]Search in Google Scholar
[7. Matz K, Jeresztes K, Tatschl C. Disorders if glucose metabolism in acute stroke patients: an unrecognized problem. Diabetes Care. 2006; 29: 792-7.10.2337/diacare.29.04.06.dc05-181816567817]Search in Google Scholar
[8. Karapanaytoides T, Piechowsky-Jozwiak B, van Melle G. Stroke patterns, ethiology and prognosis in patients with diabetes mellitus. Neurology. 2004; 62: 1558-62.10.1212/01.WNL.0000123252.55688.0515136681]Search in Google Scholar
[9. Pinto A, Tuttolomondo A, Di Raimondo D, Di Sciacca R, Fernandez P, Di Gati M, et al. A case control study between diabetic and non-diabetic subjects with ischemic stroke. Int J Cardiol. 2008 Apr 25; 125(3):391-6.10.1016/j.ijcard.2007.03.10917490764]Search in Google Scholar
[10. Shah IM, Ghosh SK, Collier A. Stroke presentation in Type 2 diabetes and the metabolic syndrome. International Angiology. 2007; 26(01): 26-31.]Search in Google Scholar
[11. Mohave MR, Hashenmazadeh M, Jamal MM. Diabetes mellitus is a strong independent risk factor for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol. 2005; 105: 315-8.10.1016/j.ijcard.2005.02.05016274775]Search in Google Scholar
[12. Fonarow GC, Srikanthan P. Diabetic cardiomyopathy. Endocrinol Metab Clin North Am. 2006; 35: 575-99.10.1016/j.ecl.2006.05.00316959587]Search in Google Scholar
[13. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med. 1995; 98: 476-84.10.1016/S0002-9343(99)80348-9]Search in Google Scholar
[14. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994; 271: 840-44.10.1001/jama.1994.03510350050036]Search in Google Scholar
[15. Lammie GA, Brannan F, Slattery J, Warlow C. Nonhypertensive cerebral small vessel disease: an autopsy study. Stroke. 1997; 28: 2222-9.10.1161/01.STR.28.11.22229368569]Search in Google Scholar
[16. Arauz A, Murrillo L, Cantu C. Prospective study of single and multiple lacunar infarct using magnetic resonance imaging: risk factors, recurrence and outcome in 175 consecutive cases. Stroke. 2003; 34: 2453-8.10.1161/01.STR.0000090351.41662.9114500936]Search in Google Scholar
[17. Rajala U, Laakso M, Painvansalo M. Blood pressure and atherosclerotic plaques in carotid, aortic and femoral arteries in elderly Finns with diabetes mellitus and impaired glucose tolerance. J Hum Hypertension. 2005; 19: 85-91.10.1038/sj.jhh.100177915343356]Search in Google Scholar
[18. Henefeld M, Koehler C, Henkel E, Fuecker K, Schaper F, Temelkova-Kurtschiev T. Postchallenge hyperglycemia relates more strongly than fasting hyperglycemia with carotid intima-media thickness: the RIAD study Diabetic Med. 2000; 17: 835-40.]Search in Google Scholar
[19. Hancu N, Cerghizam A. Global approach to Cardiovascular Risk in Type 2 Diabetic Persons. In: Hancu N. Cardiovascular Risk in Type 2 Diabetes mellitus. Springer Verlag Berlin, Heidelberg, New York. 2003: 240-76. 19b. Brohall G, Behre CJ, Hulthe J, Wikstrand J, Fagerberg B. Prevalence of diabetes mellitus and impaired glucose tolerance in 64-year-old Swedish women: experiences of using repeated oral glucose tolerance tests. Diabetes Care. 2006; 29: 363-7.10.2337/diacare.29.02.06.dc05-122916443888]Search in Google Scholar
[20. 1 IRAS, 2 Kieschl S, Willeit J, for Bruneck Study Group. The natural course of atherosclerosis, part 1: incidence and progression. Arteriosc Thromb Vasc Biol. 1999; 34: 1484-90.]Search in Google Scholar
[21. Selvin E, Coresh J, Golden SH. Glycemic control, Atherosclerosis, and Risk factors for cardiovascular Disease in Type 2 Diabetes. The Atherosclerosis Risk in Comunities Study. Diabetes Care. 2005; 28: 1963-75.]Search in Google Scholar
[22. Göksan B, Erkol G, Bozluolcay M, Ince B. Diabetes as a determinant of high-grade carotid artery stenosis: Evaluation of 1,058 cases by Doppler sonography. J Stroke Cerebrovasc Dis. 2001; 10(6): 252-6.10.1053/jscd.2001.12377317903835]Search in Google Scholar
[23. Yang B, Li TD, Wang JS, Zhi G, Jin WS, Xu Y. Insulin resistance and carotid atherosclerosis in 221 patients with potentional hyperglycemia. Chin Med Sci. 2005; 20(2): 108-11.]Search in Google Scholar
[24. Baldassarre D, de Jong A, Amato M, Werba PJ, Castelnuovo S, Frigerio B, et al. Carotid intima-media thickness and markers of inflammation endothelial damage and hemostasis. Ann Med. 2007; 1-24.10.1080/0785389070164539917934910]Search in Google Scholar
[25. Wang JG, Staessen JA, Li Y, Van Bortel LM, Nawrot T, Fagard R. Carotid intima-media thickness and antihypertensive treatment: a meta-analysis of randomized controlled trials. Ca antagonist and ACE reduce IMT. Stroke. 2006 Jul; 37(7): 1933-40.10.1161/01.STR.0000227223.90239.1316763185]Search in Google Scholar
[26. Williams R, Aiery M. Epidemiology and pathogenesis of diabetic angiopathy. In: Tooke J. Diabetic angiopathy. Arnold 1999.]Search in Google Scholar
[27. Ford ES, Giles WH, Dietz WH. Prevalence of the Metabolic Syndrome Among US Adults. JAMA 2002; 287: 356-9.10.1001/jama.287.3.35611790215]Search in Google Scholar
[28. Pollex R, Al-Shalli KZ, House AA. Relationship of metabolic syndrome to carotid ultrasound traits. Cardiovascular Ultrasound. 2006; 4: 28-35.10.1186/1476-7120-4-28153386516827932]Search in Google Scholar
[29. Lu W, Resnick HE, Jablonski KA, et al. Non-HDL Cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care. 2003; 26: 16-23.10.2337/diacare.26.1.1612502653]Search in Google Scholar
[30. Jiang R, Schulze M, Li Tricia, et al. Non-HDL Cholesterol and Apoplipoprotein B Predict Cardiovascular Disease Events Among Men With Type 2 Diabetes. Diabetes Care; 2004: 27: 1991-7.10.2337/diacare.27.8.199115277429]Search in Google Scholar
[31. De Vries R, Perton GF, Dallinga-Thie GM. Plasma cholesterol ester transfer is a determinant of intimamedia thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides. Diabetes. 2005; 54(12): 3554-9.10.2337/diabetes.54.12.355416306375]Search in Google Scholar
[32. Kawamoto R, Tomita H, Oka Y, Kodama A, Kamitami A. Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis. Intern Med. 2005; 44(12): 1232-8.10.2169/internalmedicine.44.123216415542]Search in Google Scholar
[33. Hulthe J, Bokemartk L, Wikstrand J, et al. The metabolic syndrome, LDL particle size, and atherosclerosis: The AIR study. Arterioscler Thromb Vasc Biol. 2000; 20: 2140-7.10.1161/01.ATV.20.9.2140]Search in Google Scholar
[34. Rajala U, Laakso M, Paivansalo M. Low insulin sensitivity measured by both quantitative insulin sensitive check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J Clin Endocrinol Metab. 2002; 87: 5092-7.10.1210/jc.2002-02070312414877]Search in Google Scholar
[35. Szernichow S, Bertrais S, Oppert JM, Galan P, Blacher J, Ducimetiere P, et al. Body composition and after repartition in relation to structure and function of a large arteries in middle-aged adults (the SU.VI.MAX study). Int J Obes. 2005; 29: 826-32.]Search in Google Scholar
[36. Nomura M, Kasamai R, Ohashi M, Ymada Y, Abe. H. Significantly higher invcidence of carotid atheroscelrotiss found in japanese type 2 diabetic patients with early nephropathy. Diabetes Res Clin Pract. 2004; 66(1): 161-3.10.1016/j.diabres.2003.09.01415563969]Search in Google Scholar
[37. Zhang L, Zhao F, Yang Y, Qi L, Zhang B, Wang F, et al. Association between carotid artery intimamedia thickness and early-stage CKD in a Chinese population. Am J Kidney Dis. 2007; 49(6): 786-92.10.1053/j.ajkd.2007.03.01117533021]Search in Google Scholar
[38. Tuimlehto J, Rastenyete D, Jousilahti P, Sarti C, Vartianinen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of the middleaged Finnish population. Stroke. 1996; 27: 210-5.10.1161/01.STR.27.2.2108571411]Search in Google Scholar
[39. Folsom AR, Rasmunssen ML, Chambles ME. Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ishaemic stroke. ARIC study. Diabetes Care. 1999; 22: 1077-83.10.2337/diacare.22.7.1077]Search in Google Scholar
[40. Megherbi SA, Mialn C, Minier D, et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from from the European BIOMED Stroke project. Stroke. 2003; 344: 688-94.10.1161/01.STR.0000057975.15221.40]Search in Google Scholar
[41. Bonora E, Kiechl E, Oberhollenzer F. Imparied glucose tolerance, Type 2 diabetes mellitus and carotid atherosclerosis: prospective results from the Bruneck Study. Diabetologia. 2000; 43: 156-64.10.1007/s001250050024]Search in Google Scholar
[42. Grag R, Chaudhuri A, Munscauer F. Hyperglycemia insulin and acute ischemic stroke: a mechanistic justification for a trial of insulin infusion therapy. Stroke. 20006; 37: 267-73.10.1161/01.STR.0000195175.29487.30]Search in Google Scholar
[43. Selvin E, Coresh J, Golden SH. Glycemic control, Atherosclerosis, and Risk factors for cardiovascular Disease in Type 2 Diabetes. The Atherosclerosis Risk in Communities.]Search in Google Scholar
[44. Jorgensen H, Nkayama H, Raaschou HO, Olsen TS, Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke. 1994; 25: 1977-84.10.1161/01.STR.25.10.1977]Search in Google Scholar
[45. Lithner F, Asplund K, Eriksson S, Haag E, Strand T, Wester PO. Clinical characteristics on diabetic stroke patients. Diab Metab. 1988; 14: 15-19.]Search in Google Scholar
[46. Toni D, Sacchetii Ml, Argentino C, Gentile M, Cavalleti C, Frontoni M, et al. Does hyperglycemia play a role on the outcome of ishemic stroke patients? J Neurol. 1992; 239: 382-6.]Search in Google Scholar
[47. Kiers L, Davis SM, Larkins R, Hopper J, Tress B, Rossiter SC, et al. Stroke topography and outcome in relation to hyperglicaemia and diabetes. J Neurol Neurosurg Psychiatry. 1992; 55: 263-70.10.1136/jnnp.55.4.263]Search in Google Scholar
[48. Pulsinelli WA, Levy DE, Sigsvee B, Scherer P, Plum F. Increased damage after ischemic stroke in patients with hyperglicaemia with or without established diabetes mellitus. Am J Med. 1983; 74: 540-4.10.1016/0002-9343(83)91007-0]Search in Google Scholar
[49. Peila R, Rodriquez BL, Launer LI. Type 2 diabetes, APOE Gene, and the risk for Dementia and related pathologies. Honolulu Asia-Aging study. Diabetes. 2002; 52: 1256-62.10.2337/diabetes.51.4.125611916953]Search in Google Scholar
[50. Korf ESC, White LR, Scheltens P, Launer LJ. Brain Aging in Very old men with type 2 diabetes. Diabetes Care. 2006; 29(10): 2268-74.10.2337/dc06-024317003305]Search in Google Scholar
[51. Albers GW, Dalen JE, Laupacis A. Antithrombotic therapy in atrial fibrillation. Chest. 2001; 119; 1945- 2065.10.1378/chest.119.1_suppl.194S]Search in Google Scholar
[52. Fuster V, Ryden LE, Asinger RW, Cannon DS, Crijns HJ, Frye RL, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Eur Heart J. 2006; 27: 1979-2030.]Search in Google Scholar
[53. Gage BF, Waterman AD, Shannon W. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001; 285: 2864-70.10.1001/jama.285.22.2864]Search in Google Scholar
[54. Wang TJ, Massaro JM, Levy D. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003; 290: 1049-1056.10.1001/jama.290.8.1049]Search in Google Scholar
[55. Adler A, Stratton I, Neil H. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000; 321: 17: 412-9.10.1136/bmj.321.7258.412]Search in Google Scholar
[56. Chalmers J, Joshi R, Patel A. Advances in reducing the burden of vascular disease in type 2 diabetes. Clin Exp Pharmacol Physiol. 2008 Apr; 35(4): 434-7.10.1111/j.1440-1681.2008.04892.x]Search in Google Scholar
[57. Tuomilehto J, Rastenyte D, Birkenhager WH. Effects of calcium-channel blockade on older patients with diabetes and systolic hypertension. (Syst-Eur). N Engl J Med. 1999; 340: 677-84.10.1056/NEJM199903043400902]Search in Google Scholar
[58. Soucek M. Diabetes Mellitus cerebrovascular disease. Vnitr Lek. 2003 Dec; 49(12): 916-20]Search in Google Scholar
[59. The Task Force on Diabetes and Cardiovascular Disease of the European Society of Cardiology and of the European Association of the Study of Diabetes. doi.10.1093/eurheartj/ehl261.]Search in Google Scholar
[60. Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, et al. The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy. Can J Cardiol. 2008; 24(6): 465-75.10.1016/S0828-282X(08)70620-2]Search in Google Scholar
[61. Kawamura T. Cerebrovascular disease and diabetic patients with hypertension. Nippon Rinsho. 2003 Jul; 61(7): 1175-80.]Search in Google Scholar
[62. Hirsh J, Bhatt DL. Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. Arch Intern Med. 2004; 164: 2106-10.10.1001/archinte.164.19.2106]Search in Google Scholar
[63. Bosevski M, Georgievska Lj, Borozanov V. Dual antithrombotic therapy and hypercoagulability in diabetic patients. Am Heart J. 2008; 155(6): e47.10.1016/j.ahj.2008.03.001]Search in Google Scholar
[64. Serebruany VL, Malinin AI, Pokov A, Barsness G, Hanley DF. Effects of clopidogrel and aspirin in combination versus aspirin alone on platelet activation and major receptor expression in diabetic patients: the PLavix Use for Treatment Of Diabetes (PLUTO-Diabetes) trial. Am Heart J. 2008 Jan; 155(1): 93.e1-7.10.1016/j.ahj.2007.10.006]Search in Google Scholar
[65. Williams LS, Rotich J, Qi R, Fineberg N, Espay N, Bruno A, et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology 200259; 67-71 x 68. UKPDS 33. Lancet. 1998; 352: 837-53.]Search in Google Scholar
[66. Diabetes Prevention Research Programme. reduction in the incidence of type 2 diabetes with lifestyle modification and or metformin. N Engl J Med. 2002; 346: 394-46.]Search in Google Scholar
[67. Heart protection study Collaboration Group. MRC/BHF Heart Protection Study of cholesterollowering in 5963 people with diabetes: a randomized placebo-controlled trial. Lancet. 2003; 361: 2005-16. 67b. Chambers BR, Roberts NG. Asymptomatic carotid artery stenosis. Current Treatment in Cardiovascular Medicine. 2007; 9(2): 81-89.10.1016/S0140-6736(03)13636-7]Search in Google Scholar
[68. Eton D. Surgery and Medical Management of Cerebrovascular Disease in: Eton D. Vascular Disease: A Multi-Specialty approach to Diagnosis and Management, Landes Bioscience, Austin 1999.]Search in Google Scholar
[69. Reina-Gutierrez T, Serrano-Hernanado FJ, Sanchez- Hervas L. Recurrent carotid artery stenosis following up endarterectomy: natural history and risk factors. Euro J Vasc Endovasc Surg. 2005; 29(4): 334-41.10.1016/j.ejvs.2004.10.00715749031]Search in Google Scholar
[70. Tropeano AI, Boutouyrie P, Katsahian S. Glucose level is a major determinant of carotid intima-media thickness in patients with hypertension and hyperglycemia. J Hypertension. 2004; 22(11): 2153-60.10.1097/00004872-200411000-0001815480100]Search in Google Scholar
[71. Levy EI, Mocco J, Samuelson RM, Ecker RD, Jahromi BS, Hopkins N. Optimal treatment of carotid artery disease. JACC 2008; 51(10): 979-985.10.1016/j.jacc.2007.10.05218325435]Search in Google Scholar
[72. Chambers BR, Donnan GA. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Sys Rev. 2005; 2: CD001923.10.1002/14651858.CD001923.pub2666925716235289]Search in Google Scholar
[73. Coward Lj, Featherstone RL, Brown MM. Safety and efficacy of endovascular treatment of carotid treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke. 2005; 36: 905-11.10.1161/01.STR.0000158921.51037.6415746454]Search in Google Scholar
[74. Hancu N, Cerghizan, Cornelia B. Practical approach to the multifactorial risk in type 2 diabetes. In Cheta D. Multivacsular involvement in Diabetes. Karger, Basel 2005.]Search in Google Scholar
[75. Stevens RJ, Kothari V, Adler AI, Stratton IM, Holman RR, on behalf of the UKPDS Group. The UKPDS risk engine: a model for the risk the coronary heart disease in type 2 diabetes (UKPDS 56). Clinical Science. 2001; 101: 671-9.10.1042/CS20000335]Search in Google Scholar
[76. Kothari V, Stevens RJ, Adler AJ, Stratton IM, Manley SE, Neil A, Holman RR, for the UKPDS Group (UKPDS 60) Risk for stroke in the 2 diabetes estimated by UKPDS risk engine. Stroke. 2002; 33: 776-1781.]Search in Google Scholar
[77. Song SH, Brown PM. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications. Diabetic Medicine. 2003; 21: 238-245.]Search in Google Scholar
[79. Haffner SM, Lehot S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998; 339: 229-34.10.1056/NEJM1998072333904049673301]Search in Google Scholar
[80. Doney A, Lee S, Leese G, Morris A, Palmer C. Increased Cardiovascular Morbidity and Mortality in Type 2 Diabetes Is Associated With Glutathione S Transferase Theta-Null Genotype (A Go-DARTS Study). Circulation. 2005; 111: 677-88.10.1161/CIRCULATIONAHA.104.50922415927971]Search in Google Scholar
[81. Morrish NJ, Steven LK, Head J, et al. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics) Diabetologia. 1990, 33: 542-8.10.1007/BF004041422253831]Search in Google Scholar
[82. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291(3): 335-42.10.1001/jama.291.3.33514734596]Search in Google Scholar
[83. Orchard TJ, Strandness DE Jr. Assessment of peripheral vascular disease in diabetes. Report and recommendations of an international workshop sponsored by the American Heart Association and the American Diabetes Association Diabetes Care. 1993 Aug; 16(8): 1199-209.10.2337/diacare.16.8.1199]Search in Google Scholar
[84. De Angelis M, Scrucca L, Leandri M, et al. Prevalence of carotid stenosis in type 2 diabetic patients asymptomatic for cerebrovascular disease. Diabetes Nutr Metab. 2003 Feb; 16(1): 48-55. 84b. Lacroix P, Aboyans V, Criqui MH, Bertin F, Bouhamed T, Archambeaud F, Laskar M. Type 2 diabetes and carotid stenosis: a proposal for a screening strategy in asymptomatic patients. Vascular Medicine. 2006; 11: 93-99.10.1191/1358863x06vm677oa]Search in Google Scholar
[85. Lorenz MW, Markus HS, Bots MI, et al. prediction of Clinical Cardiovascular Events with Carotid Intima- Media Thickness. Circulation. 2007; 115: 459- 467.10.1161/CIRCULATIONAHA.106.628875]Search in Google Scholar
[86. Duval M, Altman JJ. When should ultrasonography be used to detect asymptomatic carotid atheroma in diabetic patients? Diabetes Metab. 2006 Dec; 32(6): 638-42. 86b. Bosevski M, Borozanov V, Vavlukis M, Pemovska G, Georgievska-Ismail Lj. Carotid ultrasound, blood lipids and waist determination can predict a future coronary revascularisation in the type 2 diabetic cohort. Prilozi. 2007; 28(2): 127-36.]Search in Google Scholar
[87. Bernard S, Serusclar A, Targe F, et al. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005; 28(5): 1158-9.10.2337/diacare.28.5.1158]Search in Google Scholar
[88. Parikh A, Daneman D. Is Carotid Ultrasound a Useful Tool in Assessing Cardiovascular Disease in Individuals with Diabetes? Diabetes Technology & Therapeutics. 2004; 6(1): 65-9.10.1089/152091504322783440]Search in Google Scholar
[89. Yokoyama H, Katakami N, Yamasaki Y. Recent advances of intervention to inhibit progression of carotid intima-media thickness in patients with type 2 diabetes mellitus. Stroke. 2006; 37(9): 2420-7.10.1161/01.STR.0000236632.58323.cd]Search in Google Scholar
[90. Bots ML, Evans GW, Riley WA, Grobbe DE. Carotid intima-media thickness Measurements in Intervention studies. Stroke. 2003; 34: 2985-94.10.1161/01.STR.0000102044.27905.B5]Search in Google Scholar
[91. Spence JD. Ultrasound measurements of carotid plaques as a surrogate outcome for coronary artery disease. Am J Cardiol. 2002; 89 (suppl): 10B-16B.10.1016/S0002-9149(01)02327-X]Search in Google Scholar
[92. Giral P, Brucket E, Daiorrou F. Usefulness in predictting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress test. Am J Cardiol. 1999; 84: 14-17.10.1016/S0002-9149(99)00184-8]Search in Google Scholar
[93. Lee EJ, Kim HJ, Bae JM, et al. Relevance of common carotid intima-media thickness and carotid plaque as risk factors for ischemic stroke in patients with type 2 diabetes mellitus. Am J Neuroradiol. 2007; 28(5): 916-9.]Search in Google Scholar
[94. Giral P, Brucket E, Daiorrou F. Usefulness in predicting coronary artery disease by ultrasonic evaluation of the carotid arteries in asymptomatic hypercholesterolemic patients with positive exercise stress test. Am J Cardiol. 1999; 84: 14-17.10.1016/S0002-9149(99)00184-8]Search in Google Scholar
[95. Lorenz M, Markus H, Bots M, Rosval M, Sitzer M. Prediction of Clinical Cardiovascular Events with Carotid Intima-media thickness: A systematic review and Meta-analysis. Circulation. 2007; 115: 459-67. 95b. De Angelis M, Strucca L, Leandri M. Prevalence of carotis stenosis in type 2 diabetic pts asymptomatic for cerebrovascular disease. Diabetes Nutr Metab. 2003; 16: 48-55.]Search in Google Scholar
[96. Bosevski M, Influence of metabolic risk factors for presence of carotid artery disease in patients with type 2 diabetes and coronary artery disease. Diab Vasc Dis Res. 2007; 4(1): 49-52.10.3132/dvdr.2007.00617469044]Search in Google Scholar
[97. Lacroix P, Aboyans V, Criqui MH, Bertin F, Bouhamed T, Archambeaud F, Laskar M. Type-2 diabetes and carotid stenosis: a proposal for a screening strategy in asymptomatic patients. Vasc Med. 2006; 11(2): 93-9.10.1191/1358863x06vm677oa16886839]Search in Google Scholar
[98. Parikh A, Daneman D. Is Carotid Ultrasound a Useful Tool in Assessing Cardiovascular Disease in Individuals with Diabetes? Diabetes Technology & Therapeutics. 2004; 6(1): 65-9.10.1089/15209150432278344015000773]Search in Google Scholar
[99. Bosevski M, Peovska I, Georgievska-Ismail L. Noninvasive imaging of diabetic vascular disease. Review in Cardiovascular Medicine 2008; Fall (in press)]Search in Google Scholar
[100. Ragi P, Bellasi A, Ratti C. Ischemia Imaging and Plaque Imaging in Diabetes. Diabetes Care. 28: 2787-2794, 2005.10.2337/diacare.28.11.278716249559]Search in Google Scholar
[101. Charvat J, Michalova K, Chlumsky J, Horácková M, Valenta Z, Zdárska D. The significance of carotid artery plaques in the detection of coronary artery disease in asymptomatic type 2 diabetic patients. J Int Med Res. 2006; 34(1): 13-20.10.1177/14732300060340010216604819]Search in Google Scholar
[102. Mudríková T, Szabová E, Tkác I. Carotid intimamedia thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wien Klin Wochenschr. 2000; 112(20): 887-91.]Search in Google Scholar
[103. Bernard S, Sérusclat A, Targe F, Charrière S, Roth O, Beaune J, et al. Incremental predictive value of carotid ultrasonography in the assessment of coronary risk in a cohort of asymptomatic type 2 diabetic subjects. Diabetes Care. 2005; 28(5): 1158-62.10.2337/diacare.28.5.115815855582]Search in Google Scholar
[104. Kitagawa K, Hougaku H, Yamagami H, Hashimoto H, Itoh T, Shimizu Y, et al., for OSACA2 Study Group. Carotid intima-media thickness and risk of cardiovascular events in high-risk patients. Results of the Osaka Follow-Up Study for Carotid Atherosclerosis 2 (OSACA2 Study). Cerebrovasc Dis. 2007; 24(1): 35-42.10.1159/00010311417519542]Search in Google Scholar
[105. Brohall G, Oden A, Fagerberg B. Carotid artery intima-media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systemic review. Diabetic Medicine. 2005; 23: 609-616.10.1111/j.1464-5491.2005.01725.x16759301]Search in Google Scholar
[106. Hodis HM, Mack WJ, LaBree L, Seizer RH, Liu CH, Azen SR. The role of carotid intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998; 128: 262-9.10.7326/0003-4819-128-4-199802150-000029471928]Search in Google Scholar
[107. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y, et al. Carotid Intima- Media thickness in Japanese Type 2 Diabetic Subjects. Predictors of progression and relationship with incident coronary heart disease. Diabetes Care. 2000; 23(9): 1310-5.10.2337/diacare.23.9.131010977024]Search in Google Scholar
[108. Salonen R, Nyyssonen K, Porkkala E. Kuopio Atherocslerosis Prevention Study (KAPS). A population- based primary preventive trial of the effect of LDL lowering in atherosclerotic progression in carotid and femoral arteries. Circulation. 1995; 92: 1758- 64.10.1161/01.CIR.92.7.1758]Search in Google Scholar
[109. Chambless LE, Folsom AR, Davis V, Sharett R, Heiss C, Sortlie P, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1979-1998. Am J Epidemiol. 2002; 155: 38-47.10.1093/aje/155.1.3811772783]Search in Google Scholar
[110. Zuriek M, Touboul PJ, Bonithon-Kopp C, Courbon D, Berr C, Leroux C, Ducimetiere P. Cross sectional and 4-year longitudinal associations between brachial pulse pressure and common carotid intimae-media thickness in a general population. The EVA study. Stroke. 2002; 33: 550-5.]Search in Google Scholar
[111. Mackinnon AD, Jerrard Dune P, Sitzer M, Biehler A, von Kegler S, Markus HS. Rates and determinants of site-specific progression of carotid intima-media thickness: the carotid atherosclerosis progression study (CAPS). Stroke. 2004; 35: 2150-4.10.1161/01.STR.0000136720.21095.f315243147]Search in Google Scholar
[112. Go AS, Hylek EM, Phillips KA, Chang Y, Henaulst LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-75.10.1001/jama.285.18.237011343485]Search in Google Scholar
[113. AF Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from the randomized controlled trials. Arch Intern Med. 1994; 154: 1449-57.10.1001/archinte.1994.00420130036007]Search in Google Scholar
[114. Korf ES, White LR, Scheltens P, Launer LJ. Brain aging in very old men with type 2 diabetes: the Honolulu- Asia Aging Study. Diabetes. 2006; 29(10): 2268-74.]Search in Google Scholar
[115. Girdia Cb, Avogaro A, Maggini M, Lombardo F, Mannuci E, Turco S, et al. Incidence and risk factors for stroke in type 2 diabetes. Stroke. 2007; 38: 1154- 60.10.1161/01.STR.0000260100.71665.2f17332448]Search in Google Scholar
[116. Schram MT, Kostense PJ, Van Dijk RA, Dekker JM, Nijpels G, Bouter LM, et al. Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study. J Hypertens. 2002; 20(9): 1743-51.10.1097/00004872-200209000-0001712195114]Search in Google Scholar
[117. Hendbald B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intiamedia thickness and stenosis in non-diabetic subjects. Results from a cross sectional study in Malmo. Sweden. Diabet Med. 2000; 17: 299-307.]Search in Google Scholar
[118. Brohall G, Oden A, Fagberg B. Carotid artery intima- media thickness in patients with type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabetic Medicine. 2005; 23: 609-16. 118b. Najjar, SS, Scuteri A, Lakatta EG. Arterial aging. Is it an immutable ardiovascular risk factor? Hypertension. 2005; 46: 454-462.]Search in Google Scholar
[119. Zunker P, Sxhick A, Buschmann HC, Georgiadis D, Nabavi D, Edelmann M, et al. Hyperinsulinism and cerebral microangiopathy. Stroke. 1996; 27: 219-23.10.1161/01.STR.27.2.219]Search in Google Scholar
[120. Mast H, Thompson JL, Lee Sh, Mohr JR, Sacco RL. Hypertension and diabetes mellitus as determinants for multiple lacunar infarcts. Stroke. 1995; 26: 30-3.10.1161/01.STR.26.1.307839393]Search in Google Scholar